Company Filing History:
Years Active: 2019-2020
Title: Sally Bayer - Innovator in Transaminase Technology
Introduction
Sally Bayer is a prominent inventor based in Leipzig, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of transaminases. With a total of two patents to her name, her work has garnered attention for its innovative applications.
Latest Patents
Sally Bayer's latest patents focus on transaminases, which are enzymes that catalyze the conversion of amines to ketones and vice versa. One of her inventions relates to transaminases that are particularly useful for this conversion process. The transaminase (ATA) she developed comprises an amino acid sequence with at least 80% homology to SEQ ID NO:1, with specific engineered substitutions that enhance its functionality. These substitutions include variations such as F255L, F255A, and several others, which optimize the enzyme's performance in catalyzing reactions.
Career Highlights
Sally Bayer has established herself as a key figure in her field through her innovative research and development efforts. Her work at C-lecta GmbH has positioned her at the forefront of biotechnological advancements, particularly in enzyme technology. Her contributions have not only advanced scientific understanding but also have practical implications in various industrial applications.
Collaborations
Sally collaborates with notable colleagues, including Andreas Vogel and Daniel Schwarze. Their combined expertise fosters a dynamic research environment that enhances the development of innovative solutions in biochemistry.
Conclusion
Sally Bayer's work in transaminase technology exemplifies the impact of innovative thinking in the field of biochemistry. Her patents reflect a commitment to advancing scientific knowledge and practical applications. Through her career, she continues to inspire future generations of inventors and researchers.